Kim Hyo-Sin, Choi Soo Jin Na, Lee Ho Kyun, Lee Sola
Department of Surgery, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea.
Korean J Transplant. 2023 Dec 31;37(4):306-309. doi: 10.4285/kjt.23.0070.
Liver transplantation is a critical procedure for patients with end-stage liver disease, but it is often hindered by ABO-incompatibility between the donor and recipient, which can lead to immediate humoral rejection. We present a unique case involving a 10-month-old patient who, by accident, received an ABO-incompatible partial liver transplant from a type A mother without undergoing desensitization. Remarkably, during a 21-year follow-up period, the patient exhibited no signs of humoral or graft rejection, despite nonadherence to medication. This case highlights the possibility of dual tolerance in pediatric ABO-incompatible liver transplantation and provides insights into immune tolerance mechanisms, with implications for enhancing patient care and reducing healthcare costs. Further research is necessary to clarify these mechanisms and to evaluate the long-term durability of tolerance in pediatric transplant recipients.
肝移植是终末期肝病患者的关键治疗手段,但供体与受体之间的ABO血型不相容常常会阻碍肝移植,这可能导致即刻体液排斥反应。我们报告了一例独特病例,一名10个月大的患儿意外接受了来自A型母亲的ABO血型不相容部分肝移植,且未进行脱敏治疗。值得注意的是,在21年的随访期内,尽管该患儿未坚持用药,但未出现体液或移植物排斥反应的迹象。该病例凸显了小儿ABO血型不相容肝移植中双重耐受的可能性,并为免疫耐受机制提供了见解,对改善患者护理和降低医疗成本具有重要意义。有必要进一步开展研究以阐明这些机制,并评估小儿移植受者耐受的长期持久性。